Top

Indian Journal of Otolaryngology and Head & Neck Surgery

Published in:

01-11-2019 | Original Article

Sinonasal Mucormycosis: A to Z

Authors: V. P. Singh, Chetan Bansal, Madhuri Kaintura

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Special Issue 3/2019

Abstract

Mucormycosis caused by one of the members of Mucoraceae family, is one of the most rapidly spreading and fatal fungal infection occurring mostly in Diabetic or Immunocompromised patients especially in developing countries. 26 patients suffering from sinonasal mucormycosis admitted in SGRRIM&HS, Dehradun from January 2013 to January 2017 are discussed. Diagnosis of mucormycosis was established on strong clinical suspicion with presence of grayish black crusting on nasal endoscopy which is confirmed by histopathology examination. Immediate correction of underlying immunocompromised status with debridement with intravenous liposomal amphotericin B was done in all the 26 cases out of which 10 patients were cured. Early detection and aggressive multidisciplinary management is must for the successful treatment of mucormycosis.

Soni A (2017) Paranasal mucormycosis in an immunocompetent individual: importance of early diagnosis. Int J Oral Health Med Res 4(3):52–56

Prabhu RM, Patel R (2004) Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 10(Suppl. 1):31–47CrossRef

Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Javier F, del Cañizo-Gómez. FJ (2014) Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes 5(4):444–470CrossRef

Karthikeyan P, Nirmal Coumare V (2010) Incidence and presentation of fungal sinusitis in patient diagnosed with chronic rhinosinusitis. Indian. J Otolaryngol Head Neck Surg 62(4):381–385

Gavito-Higuera J, Mullins CB, Ramos-Duran L, Sandoval H, Akle N, Figueroa R (2016) Sinonasal fungal infections and complications: a pictorial review. J Clin Imaging Sci 6:23CrossRef

Deshazo RS (2009) Syndromes of invasive fungal sinusitis. Med Mycol 47(1):S309–S314CrossRef

Ananthaneni AR, Undavalli SB, Velagapudi RP, Guduru VS (2013) Mucormycosis: an atrocious mate of patients with diabetes. BMJ Case Rep. https://doi.org/10.1136/bcr-2013-009600 CrossRefPubMedPubMedCentral

Wali U, Balkhair A, Al-Mujaini A (2012) Cerebro-rhino orbital mucormycosis: an update. J Infect Public Health 5(2):116–126CrossRef

Lunge SB, Sajjan V, Pandit AM, Patil VB (2015) Rhinocerebrocutaneous mucormycosis caused by Mucor species: a rare causation. Indian Dermatol Online J 6(3):189–192CrossRef

10.

Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP (2012) Pathogenesis of mucormycosis. Clin Infect Dis 54(1):S16–S22CrossRef

11.

Munjal M, Khurana AS (2004) Fungal infections and cavernous sinus thrombosis. Indian J Otolaryngol Head Neck Surg 56(3):235–237PubMedPubMedCentral

12.

Badiee P, Arastefar A, Jafarian H (2013) Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens. Iran J Microbiol 5(4):406–410PubMedPubMedCentral

13.

Sree Vijayabala G, Annigeri RG, Sudarshan R (2013) Mucormycosis in a diabetic ketoacidosis patient. Asian Pac J Trop Biomed 3(10):830–833CrossRef

14.

Spellberg B, Edwards J Jr, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18(3):556–569CrossRef

15.

Guarner J, Brandt ME (2011) Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 24(2):247–280CrossRef

16.

Gamba JL, Woodruff WW, Djang WT, Yeates AE (1986) Craniofacial mucormycosis: assessment with CT. Radiology 160:207–212CrossRef

17.

Neumann A, Baginski M, Czub J (2010) How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets. J Am Chem Soc 132(51):18266–18272CrossRef

18.

Hamill RJ (2013) Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs 73:919–934CrossRef

19.

Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, Kontoyiannis DP, Walsh TJ (2012) Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis 54(1):S73–S78CrossRef

20.

Goldstein EJC, Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS (2009) Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 48(12):1743–1751CrossRef

21.

Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J (1988) Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 10(3):551–559CrossRef

Title: Sinonasal Mucormycosis: A to Z
Authors: V. P. Singh
Chetan Bansal
Madhuri Kaintura
Publication date: 01-11-2019
Publisher: Springer India
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery / Issue Special Issue 3/2019
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-018-1384-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Sinonasal Mucormycosis: A to Z

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 3/2019

Nasal Endoscopy as an Effective Alternative for CT-Scan in Diagnosing Chronic Rhinosinusitis: A Clinical Study and Review of Literature

Ossifying Fibroma of Maxilla in a Female Affected by Neurofibromatosis Type 1

Respiratory Epithelial Adenomatoid Hamartoma (REAH) in the Olfactory Cleft: Often Masked by Bilateral Nasal Polyps

An Ayurvedic Management of Nasal Polyposis

Treatment of Allergic Rhinitis: A Comparative Study of Traditional Antihistamine oral Rupatidine Versus Oral Rupatidine with a Lipid Based Nasal Ointment

Effectiveness of Nasal Packing in Trans-septal Suturing Technique in Septoplasty: A Randomized Comparative Study